These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16898184)

  • 41. [Secondary hypertension in extended congenital stenosis of the abdominal aorta with renal artery stenosis].
    Sandhage K
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):378-9. PubMed ID: 876174
    [No Abstract]   [Full Text] [Related]  

  • 42. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
    Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
    Lupus; 2011 Feb; 20(2):165-73. PubMed ID: 21303833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual vascular focal high-grade arterial stenoses in a young woman with systemic lupus erythematosus and secondary antiphospholipid syndrome.
    Hügli RW; Gremmelmaier D; Jeanneret C; Koella C; Jehle AW; Tyndall A; Biedermann BC
    Lupus; 2011 Mar; 20(3):311-4. PubMed ID: 21362753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arterial compliance: is it reduced in antiphospholipid syndrome?
    Reitblat T; Polishchuk I; Zamir D; Isakov I; Oren S
    J Hum Hypertens; 2006 Jul; 20(7):504-9. PubMed ID: 16625240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.
    Taipa R; Santos E
    Lupus; 2011 Nov; 20(13):1433-5. PubMed ID: 21768180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS).
    Amigo MC; Goycochea-Robles MV; Espinosa-Cuervo G; Medina G; Barragán-Garfias JA; Vargas A; Jara LJ
    Lupus; 2015 Aug; 24(9):927-34. PubMed ID: 25767071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS).
    Schofield JR; Blitshteyn S; Shoenfeld Y; Hughes GR
    Lupus; 2014 Jun; 23(7):697-702. PubMed ID: 24569396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac involvement in the antiphospholipid syndrome.
    Tenedios F; Erkan D; Lockshin MD
    Lupus; 2005; 14(9):691-6. PubMed ID: 16218469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
    Kriseman YL; Nash JW; Hsu S
    J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathogenic mechanisms of the anti-phospholipid antibodies].
    Núñez-Álvarez CA; Cabiedes J
    Reumatol Clin; 2011; 7(1):72-6. PubMed ID: 21794784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
    Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
    Lupus; 2011 Feb; 20(2):174-81. PubMed ID: 21303834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary antiphospholipid syndrome: a distinct entity?
    Mackworth-Young C
    Autoimmun Rev; 2006 Jan; 5(1):70-5. PubMed ID: 16338214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.
    Cervera R; Espinosa G; Cordero A; Oltra MR; Unzurrunzaga A; Rossiñol T; Plaza J; Bucciarelli S; Ramos-Casals M; Ingelmo M; Asherson RA; Font J;
    Semin Arthritis Rheum; 2007 Apr; 36(5):287-96. PubMed ID: 17207521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney disease in antiphospholipid syndrome.
    Amigo MC
    Rheum Dis Clin North Am; 2006 Aug; 32(3):509-22. PubMed ID: 16880081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in the antiphospholipid antibody syndrome.
    Chaturvedi S; McCrae KR
    Curr Opin Hematol; 2014 Sep; 21(5):371-9. PubMed ID: 25023470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.